{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:18:09Z","timestamp":1789777089031,"version":"4.0.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Acute myeloid leukemia (AML) is a heterogeneous malignant disease. <jats:italic>SLC25A1<\/jats:italic>, the gene encoding mitochondrial carrier subfamily of solute carrier proteins, was reported to be overexpressed in certain solid tumors. However, its expression and value as prognostic marker has not been assessed in AML.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We retrieved RNA profile and corresponding clinical data of AML patients from the Beat AML, TCGA, and TARGET databases (TARGET_AML). Patients in the TCGA cohort were well-grouped into two group based on <jats:italic>SLC25A1<\/jats:italic> and differentially expressed genes were determined between the <jats:italic>SLC25A1<\/jats:italic> high and low group. The expression of <jats:italic>SLC25A1<\/jats:italic> was validated with clinical samples. The survival and apoptosis of two AML cell lines were analyzed with <jats:italic>SLC25A1<\/jats:italic> inhibitor (CTPI-2) treatment. Cox and the least absolute shrinkage and selection operator (LASSO) regression analyses were applied to Beat AML database to identify <jats:italic>SLC25A1<\/jats:italic>-associated genes for the construction of a prognostic risk-scoring model. Survival analysis was performed by Kaplan-Meier and receiver operator characteristic curves.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our analysis revealed that high expressed level of <jats:italic>SLC25A1<\/jats:italic> in AML patients correlates with unfavorable prognosis. Moreover, <jats:italic>SLC25A1<\/jats:italic> expression was positively associated with metabolism activity. We further demonstrated that the inhibition of <jats:italic>SLC25A1<\/jats:italic> could inhibit the proliferation and increase the apoptosis of AML cells. In addition, a panel of <jats:italic>SLC25A1<\/jats:italic>-associated genes, was identified to construct a prognostic risk-scoring model. This <jats:italic>SLC25A1<\/jats:italic>-associated prognostic signature (SPS) is an independent risk factor with high area under curve (AUC) values of receiver operating characteristic (ROC) curves. A high SPS in leukemia patients is associated with poor survival. A Prognostic nomogram including the SPS and other clinical parameters, was constructed and its predictive efficiency was confirmed.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> We have successfully established a SPS prognostic model that predict outcome and risk stratification in AML. This risk model can be used as an independent biomarker to assess prognosis of AML.<\/jats:p>","DOI":"10.3389\/fgene.2022.1081262","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T14:16:12Z","timestamp":1673014572000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Fangshu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suqi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"eaar5551","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: Lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/cells8090967","article-title":"Targeting metabolic reprogramming in acute myeloid leukemia","volume":"8","author":"Castro","year":"2019","journal-title":"Cells"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.18632\/oncotarget.714","article-title":"The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis","volume":"3","author":"Catalina-Rodriguez","year":"2012","journal-title":"Oncotarget"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML","volume":"378","author":"Dinardo","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/ajh.25975","article-title":"Acute myeloid leukemia: 2021 update on risk-stratification and management","volume":"95","author":"Estey","year":"2020","journal-title":"Am. J. Hematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41418-018-0101-z","article-title":"The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer","volume":"25","author":"Fernandez","year":"2018","journal-title":"Cell Death Differ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"152625","DOI":"10.1016\/j.prp.2019.152625","article-title":"Down-regulation of UTP23 promotes paclitaxel resistance and predicts poorer prognosis in ovarian cancer","volume":"215","author":"Fu","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.3390\/cancers13225608","article-title":"Venetoclax in acute myeloid leukemia: Molecular basis, evidences for preclinical and clinical efficacy and strategies to target resistance","volume":"13","author":"Garciaz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1074\/jbc.RA118.004712","article-title":"Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells","volume":"294","author":"Gayle","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/cancers14071689","article-title":"Refining AML treatment: The role of genetics in response and resistance evaluation to new agents","volume":"14","author":"Halik","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/leu.2014.124","article-title":"DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: Associations with prognosis and potential treatment strategies","volume":"28","author":"Im","year":"2014","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41420-021-00684-w","article-title":"Upregulation of CPNE7 in mesenchymal stromal cells promotes oral squamous cell carcinoma metastasis through the NF-\u03baB pathway","volume":"7","author":"Ji","year":"2021","journal-title":"Cell Death Discov."},{"key":"B14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1182\/blood.2019898114","article-title":"Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II","volume":"134","author":"Jones","year":"2019","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13057","DOI":"10.3390\/ijms222313057","article-title":"Emerging role of TCA cycle-related enzymes in human diseases","volume":"22","author":"Kang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tibs.2013.07.004","article-title":"Stress granules and cell signaling: More than just a passing phase?","volume":"38","author":"Kedersha","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1038\/nrdp.2016.10","article-title":"Acute myeloid leukaemia","volume":"2","author":"Khwaja","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: Emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1038\/s41388-018-0673-6","article-title":"Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism","volume":"38","author":"Mann","year":"2019","journal-title":"Oncogene"},{"key":"B20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bcp.2013.03.021","article-title":"A comprehensive machine-readable view of the mammalian cholesterol biosynthesis pathway","volume":"86","author":"Mazein","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00018-005-5386-7","article-title":"The Nudix hydrolase superfamily","volume":"63","author":"Mclennan","year":"2006","journal-title":"Cell Mol. Life Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.3390\/ijms21124405","article-title":"Multifaceted roles of mitochondrial components and metabolites in metabolic diseases and cancer","volume":"21","author":"Nakhle","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B23","unstructured":"AML2022"},{"key":"B24","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","article-title":"Advances in acute myeloid leukemia","volume":"375","author":"Newell","year":"2021","journal-title":"Bmj"},{"key":"B25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ajhg.2013.03.009","article-title":"Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria","volume":"92","author":"Nota","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jmoldx.2015.06.004","article-title":"Detection of dual IDH1 and IDH2 mutations by targeted next-generation sequencing in acute myeloid leukemia and myelodysplastic syndromes","volume":"17","author":"Platt","year":"2015","journal-title":"J. Mol. Diagn"},{"key":"B27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","article-title":"Molecular biomarkers in acute myeloid leukemia","volume":"31","author":"Prada-Arismendy","year":"2017","journal-title":"Blood Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41408-020-0323-4","article-title":"Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century","volume":"10","author":"Pulte","year":"2020","journal-title":"Blood Cancer J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.010","article-title":"Potentiating SLC transporter activity: Emerging drug discovery opportunities","volume":"135","author":"Rives","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1182\/blood.2020006785","article-title":"BCL2 and MCL1 inhibitors for hematologic malignancies","volume":"138","author":"Roberts","year":"2021","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tibs.2019.11.001","article-title":"The SLC25 mitochondrial carrier family: Structure and mechanism","volume":"45","author":"Ruprecht","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/cancers12113225","article-title":"Advances in acute myeloid leukemia: Recently approved therapies and drugs in development","volume":"12","author":"Stanchina","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1182\/blood-2018-08-869008","article-title":"Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib","volume":"133","author":"Stein","year":"2019","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B35","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.molcel.2018.04.021","article-title":"ZFAND1 recruits p97 and the 26S proteasome to promote the clearance of arsenite-induced stress granules","volume":"70","author":"Turakhiya","year":"2018","journal-title":"Mol. Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2020.07.009","article-title":"Induction of a timed metabolic collapse to overcome cancer chemoresistance","volume":"32","author":"Van Gastel","year":"2020","journal-title":"Cell Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: Analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41419-021-04411-2","article-title":"SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"617289","DOI":"10.3389\/fonc.2021.617289","article-title":"Derivation and validation of a prognostic model for cancer dependency genes based on CRISPR-cas9 in gastric adenocarcinoma","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1081262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T14:16:17Z","timestamp":1673014577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1081262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":40,"alternative-id":["10.3389\/fgene.2022.1081262"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.1081262","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"article-number":"1081262"}}